心血管病防治知识(下半月)
心血管病防治知識(下半月)
심혈관병방치지식(하반월)
XINXUEGUANBING FANGZHI ZHISHI
2013年
11期
22-24
,共3页
胺碘酮%恶性心律失常%治疗效果
胺碘酮%噁性心律失常%治療效果
알전동%악성심률실상%치료효과
Amiodarone%Malignant arrhythmia%Efficacy
目的对胺碘酮不同给药方法治疗恶性心律失常的临床疗效进行观察和探讨。方法选择50例于2012年1月至2013年7月间在我院进行恶性心律失常治疗的患者资料进行研究和分析,将患者分为对照组和治疗组两组,每组各有25例患者,对对照组患者进行胺碘酮治疗,对治疗组患者进行胺碘酮联合门冬氨酸钾镁治疗,比较和分析两组患者的治疗效果。结果对照组8例患者治疗显效,9例患者治疗有效,8例患者治疗无效,治疗总有效率为68%,治疗组15例患者治疗显效,9例患者治疗有效,1例患者治疗无效,治疗总有效率为96%,两组患者治疗效果差异具有统计学意义(P<0.05)。对照组患者药物起效时间为明显长于治疗组患者,两组患者药物起效时间差异具有统计学意义(P<0.05)。两组患者不良反应发生情况差异不具有统计学意义(P>0.05)。结论对恶性心律失常患者进行胺碘酮联合门冬氨酸钾镁治疗能够取得更加理想的治疗效果,值得推广和应用。
目的對胺碘酮不同給藥方法治療噁性心律失常的臨床療效進行觀察和探討。方法選擇50例于2012年1月至2013年7月間在我院進行噁性心律失常治療的患者資料進行研究和分析,將患者分為對照組和治療組兩組,每組各有25例患者,對對照組患者進行胺碘酮治療,對治療組患者進行胺碘酮聯閤門鼕氨痠鉀鎂治療,比較和分析兩組患者的治療效果。結果對照組8例患者治療顯效,9例患者治療有效,8例患者治療無效,治療總有效率為68%,治療組15例患者治療顯效,9例患者治療有效,1例患者治療無效,治療總有效率為96%,兩組患者治療效果差異具有統計學意義(P<0.05)。對照組患者藥物起效時間為明顯長于治療組患者,兩組患者藥物起效時間差異具有統計學意義(P<0.05)。兩組患者不良反應髮生情況差異不具有統計學意義(P>0.05)。結論對噁性心律失常患者進行胺碘酮聯閤門鼕氨痠鉀鎂治療能夠取得更加理想的治療效果,值得推廣和應用。
목적대알전동불동급약방법치료악성심률실상적림상료효진행관찰화탐토。방법선택50례우2012년1월지2013년7월간재아원진행악성심률실상치료적환자자료진행연구화분석,장환자분위대조조화치료조량조,매조각유25례환자,대대조조환자진행알전동치료,대치료조환자진행알전동연합문동안산갑미치료,비교화분석량조환자적치료효과。결과대조조8례환자치료현효,9례환자치료유효,8례환자치료무효,치료총유효솔위68%,치료조15례환자치료현효,9례환자치료유효,1례환자치료무효,치료총유효솔위96%,량조환자치료효과차이구유통계학의의(P<0.05)。대조조환자약물기효시간위명현장우치료조환자,량조환자약물기효시간차이구유통계학의의(P<0.05)。량조환자불량반응발생정황차이불구유통계학의의(P>0.05)。결론대악성심률실상환자진행알전동연합문동안산갑미치료능구취득경가이상적치료효과,치득추엄화응용。
Objective To observe and investigate the clinical efficacy of different usages of amiodarone in the treatment of malignant arrhythmia. Methods The clinical data of 50 patients with malignant arrhythmia treated in our hospital from January 2012 to July 2013 were investigated and analyzed. The patients were divided into control group (n=25) and treatment group (n=25). The control group was treated with amiodarone, while the treatment group was treated with amiodarone combined with potassium magnesium aspartate. The efficacy was analyzed and compared between the two groups. Results In the control group, 8 cases showed marked response, 9 cases showed response, and 8 cases showed no response, with an overall response rate of 68%, while in the treatment group, 15 cases showed marked response, 9 cases showed response, and 1 case showed no response, with an overall response rate of 96%; there was significant difference in treatment outcome between the two groups (P<0.05). The onset time in the control group was significantly longer than that in the treatment group (P<0.05). There was no significant difference in incidence of adverse reactions between the two groups (P>0.05).ConclusionAmiodarone combined with potassium magnesium aspartate can achieve more ideal efficacy in the treatment of malignant arrhythmia and is worthy of clinical application and promotion.